Reaction
Application Site Discharge reporting signals
As of the last recalculation, Application Site Discharge appears in 1,144 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is BUPRENORPHINE (PRR 44.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Buprenorphine | 188 | 44.0 | 44.1 |
| Glycerin, Lidocaine | 21 | 27.8 | 27.8 |
| Docosanol | 21 | 26.5 | 26.6 |
| Minoxidil Foam 5% (Womens) | 36 | 20.5 | 20.5 |
| Estradiol | 85 | 19.3 | 19.3 |
| Minoxidil | 41 | 17.2 | 17.2 |
| Crisaborole | 6 | 11.4 | 11.4 |
| Nicotine | 23 | 10.5 | 10.5 |